+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Theravance Biopharma - logo

Theravance Biopharma is a biopharmaceutical company that develops and commercializes human therapeutics. The company offers VIBATIV (telavancin), a bactericidal, once-daily injectable antibiotic. In addition, it has numerous product candidates, including Revefenacin (TD-4208), Axelopran, Velusetrag, TD-6450 and others. It also focuses on various drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. Founded in 2013, it is based in George Town, the Cayman Islands.

Peptide Antibiotics Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type - Product Thumbnail Image

Peptide Antibiotics Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • November 2023
  • 115 Pages
  • Global
From
Diabetic Gastroparesis (DGp) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Diabetic Gastroparesis (DGp) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • June 2024
  • 200 Pages
  • Global
From
Janus Kinase (JAK) Inhibitors Market Report 2025 - Product Thumbnail Image

Janus Kinase (JAK) Inhibitors Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Diabetic Gastroparesis Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Diabetic Gastroparesis Treatment Market Report and Forecast 2024-2032

  • Report
  • October 2024
  • 200 Pages
  • Global
From
Anti Asthmatic Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Anti Asthmatic Drugs Global Market Insights 2022, Analysis and Forecast to 2027, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • March 2022
  • 101 Pages
  • Global
From
Diabetic Gastroparesis - Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Gastroparesis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 541 Pages
  • Global
From
Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2025 - Product Thumbnail Image

Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2025

  • Report
  • September 2025
  • 450 Pages
  • Global
From
Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Hypertension Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 589 Pages
  • Global
From
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025 - Product Thumbnail Image

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025

  • Report
  • September 2025
  • 750 Pages
  • Global
From
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2025 - Product Thumbnail Image

Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2025

  • Report
  • September 2025
  • 300 Pages
  • Global
From
Pneumatic Nebulizers Market Analysis & Forecast to 2024-2034 - Product Thumbnail Image

Pneumatic Nebulizers Market Analysis & Forecast to 2024-2034

  • Report
  • January 2024
  • 200 Pages
  • Global
From
Autoimmune Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Autoimmune Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 500 Pages +
  • Global
From
Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 693 Pages
  • Global
From
Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target Antigens and Key Geographical Regions - Product Thumbnail Image

Antibody Drug Conjugate Market Industry Trends and Global Forecasts to 2035, by Target Disease Indication, Therapeutic Area, Linker, Payload, Target Antigens and Key Geographical Regions

  • Report
  • November 2024
  • 716 Pages
  • Global
From
Gastroparesis Drugs - Global Strategic Business Report - Product Thumbnail Image

Gastroparesis Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 197 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease Drugs Market 2025-2029 - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease Drugs Market 2025-2029

  • Report
  • July 2025
  • 229 Pages
  • Global
From
Orthostatic Hypotension Drugs - Global Strategic Business Report - Product Thumbnail Image

Orthostatic Hypotension Drugs - Global Strategic Business Report

  • Report
  • October 2025
  • 286 Pages
  • Global
From
Mu Antagonist - Pipeline Insight, 2025 - Product Thumbnail Image

Mu Antagonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Gastroparesis Drugs Market 2025-2029 - Product Thumbnail Image

Gastroparesis Drugs Market 2025-2029

  • Report
  • December 2024
  • 198 Pages
  • Global
From
Loading Indicator